MedTrace Logo

A Study to Compare Pharmacokinetics of GB1211

NCT05747573 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2023-09-01

No results posted yet for this study

Summary

This study is an open label, Randomized, Three-period, Crossover Study to Compare the Pharmacokinetics of GB1211 upon Dosing a Capsule under Fasting Condition and a Tablet under Fasting and Fed Conditions in Healthy Volunteers

Conditions

  • Pharmacokinetics

Interventions

DRUG

GB1211

Hard tablet or capsules for oral use

Sponsors & Collaborators

  • QPS Holdings LLC

    collaborator INDUSTRY

  • Galecto Biotech AB

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-03
Primary Completion
2023-04-10
Completion
2023-04-10

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05747573 on ClinicalTrials.gov